Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
Deguchi
Kazushi
K
Sasaki
Iwao
I
Touge
Tetsuo
T
Tsukaguchi
Masago
M
Ikeda
Kazuyo
K
Shimamura
Mieko
M
Urai
Yoshiteru
Y
Watanabe
Seishiro
S
Takeuchi
Hiroaki
H
Kuriyama
Shigeki
S
D002319:Cardiovascular System / Q000187:drug effects* / Q000503:physiopathology; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003300:Copper / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D014266:Trientine / Q000494:pharmacology / Q000627:therapeutic use*
D002614:Chelating Agents; D003300:Copper; D014266:Trientine
AJR Am J Roentgenol. 1996 Dec;167(6):1579-84
8956601
Q J Med. 1990 Jun;75(278):597-605
2217665
Acta Neurol Scand. 1982 Jan;65(1):71-5
6175159
Chest. 1987 Apr;91(4):579-83
3829752
J Neurol Sci. 1997 Aug;149(2):131-7
9171319
Clin Auton Res. 2002 Jun;12(3):139-40
12269542
Clin Auton Res. 2002 Jun;12(3):190-2
12269552
J Comput Assist Tomogr. 1995 Jul-Aug;19(4):635-8
7622700
Clin Auton Res. 2002 Jun;12(3):185-9
12269551